Clinical trial
A Randomized Double-blind Study to Evaluate the Safety and Efficacy of Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
NCT01732770 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double-blind Study to Evaluate the Safety and Efficacy of Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- Lead sponsor
- Amgen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 7, 2012
- Completion date
- January 7, 2015
- Enrollment
- 643 (actual)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.
post menopausal osteoporosis